Benzinga | Mar 15, 2021 04:05PM EDT

Amphastar Pharmaceuticals Q4 Adj. EPS $0.16 Beats $0.14 Estimate, Sales $95.90M Beat $88.94M Estimate

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. This is a 128.57 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $95.90 million which beat the analyst consensus estimate of $88.94 million by 7.83 percent. This is a 15.01 percent increase over sales of $83.38 million the same period last year.